Publicação

The contribution of genetics to the understanding and management of cardiomyopathies

Ver documento

Detalhes bibliográficos
Resumo:Cardiomyopathies may present as a manifestation of various inherited syndromes. Recognizing the rarity and diagnostic challenges of syndromic and metabolic cardiomyopathies is crucial, as their identification holds significant implications for targeted treatment and enables the use of specific risk stratification tools. Genetics has assumed a pivotal role in clarifying the pathophysiology of cardiomyopathies, facilitating molecular diagnosis, and enabling effective family screening. The advent of next-generation sequencing has revolutionized genetic testing, enabling cost-effective, high-throughput analyses, facilitating the diagnosis of these rare conditions, and allowing the provision of specific management and therapeutics.
Autores principais:Cardoso, Isabel
Outros Autores:Melo, Mafalda; Brás, Pedro; Viegas, José Miguel; Almeida, Inês; Nunes, Sofia; Custódio, Inês; Trigo, Conceição; Laranjo, Sérgio; Laranjo, Sergio; Graça, Rafael; Cruz Ferreira, Rui; Oliveira, Mário; Martins; Aguiar Rosa, Sílvia; Antunes, Diana
Assunto:Genetics Genotype Metabolic cardiomyopathies Risk stratification Syndromic cardiomyopathies Cardiology and Cardiovascular Medicine
Ano:2025
País:Portugal
Tipo de documento:recensão
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
Descrição
Resumo:Cardiomyopathies may present as a manifestation of various inherited syndromes. Recognizing the rarity and diagnostic challenges of syndromic and metabolic cardiomyopathies is crucial, as their identification holds significant implications for targeted treatment and enables the use of specific risk stratification tools. Genetics has assumed a pivotal role in clarifying the pathophysiology of cardiomyopathies, facilitating molecular diagnosis, and enabling effective family screening. The advent of next-generation sequencing has revolutionized genetic testing, enabling cost-effective, high-throughput analyses, facilitating the diagnosis of these rare conditions, and allowing the provision of specific management and therapeutics.